Literature DB >> 12110516

The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion.

Thomas Ludwig1, Rainer Ossig, Susanne Graessel, Marianne Wilhelmi, Hans Oberleithner, Stefan W Schneider.   

Abstract

The electrical resistance breakdown of the Madin-Darby canine kidney (MDCK) cell monolayer provides a continuous assay system for cancer invasion that detects functional changes before morphological alterations. In this study, we address the question of whether physical contact between tumor cell and epithelial monolayer is a prerequisite for tumor cell invasion. When human melanoma cells were seeded directly (i.e., physical contact) on top of an electrically tight epithelial cell layer (5,800 +/- 106 Omega x cm2), electrical monolayer leakage led to an 18 +/- 3% reduction of transepithelial electrical resistance within 24 h. However, when melanoma cells were seeded close to the basolateral surface of the epithelial cell monolayer but separated by a filter membrane (i.e., no physical contact), electrical leakage occurred even more quickly (42 +/- 3% reduction in 24 h). Atomic force microscopy detected discrete structural changes between cells. Electrical leakage was effectively blocked by alpha2-macroglobulin or ilomastat, inhibitors of matrix metalloproteinases. We conclude that exocytosis of soluble proteases causes electrical breakdown of the MDCK monolayer, independently of physical contact between tumor cells and the monolayer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110516     DOI: 10.1152/ajprenal.00327.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  9 in total

Review 1.  Probing cellular microenvironments and tissue remodeling by atomic force microscopy.

Authors:  Thomas Ludwig; Robert Kirmse; Kate Poole; Ulrich S Schwarz
Journal:  Pflugers Arch       Date:  2007-12-06       Impact factor: 3.657

2.  Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.

Authors:  Y Yang; C Gorzelanny; A T Bauer; N Halter; D Komljenovic; T Bäuerle; L Borsig; M Roblek; S W Schneider
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

3.  The extracellular matrix remodeled: Interdependency of matrix proteolysis, cell adhesion, and force sensing.

Authors:  Robert Kirmse; Hannes Otto; Thomas Ludwig
Journal:  Commun Integr Biol       Date:  2012-01-01

4.  Evaluation of head and neck squamous cell carcinoma invasiveness by the electrical resistance breakdown assay.

Authors:  Robert Mandic; Thomas Ludwig; Hans Oberleithner; Jochen Alfred Werner
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase.

Authors:  Thomas Ludwig; Sarah M Theissen; Michael J Morton; Michael J Caplan
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  New tools for assessing the individual risk of metastasis in renal cell carcinoma.

Authors:  Edwin Herrmann; Carsten Weishaupt; Birgit Pöppelmann; Carina Hillgruber; Gerald Pühse; Laura Maria Krabbe; Micha Feld; Martin Steinhoff; Tobias Goerge
Journal:  Clin Exp Metastasis       Date:  2012-08-23       Impact factor: 5.150

Review 7.  [Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].

Authors:  C Bolenz; T Martini; M S Michel
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

8.  Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7.

Authors:  Christian Bolenz; Daniel Knauf; Axel John; Philipp Erben; Annette Steidler; Stefan W Schneider; Cagatay Günes; Christian Gorzelanny
Journal:  Bladder Cancer       Date:  2018-01-20

9.  Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.

Authors:  Wiebke K Peitsch; Yvette Doerflinger; Reiner Fischer-Colbrie; Volker Huck; Alexander T Bauer; Jochen Utikal; Sergij Goerdt; Stefan W Schneider
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.